{
  "release_id": "a25293eeae6350fb",
  "id": "cardio:nebivolol",
  "owner": "cardio",
  "kind": "drug",
  "slug": "nebivolol",
  "name": "Nebivolol",
  "aliases": [
    "Bystolic"
  ],
  "atlases": [
    "cardio"
  ],
  "summary_plain": "Nebivolol is a beta-blocker taken by mouth. The US label read, for Bystolic, lists one use: the treatment of hypertension, to lower blood pressure.",
  "summary_technical": "RxNorm ingredient 31555; UNII JGS34J7L9I. The label names the substance as nebivolol hydrochloride, so UNII JGS34J7L9I is the UNII of the hydrochloride salt and is a broad match. MeSH descriptor D000068577 is Nebivolol. Class: beta-Adrenergic Blocker (FDA established pharmacologic class, RxClass). The label read is the Allergan, Inc. label for BYSTOLIC (nebivolol hydrochloride), application NDA021742, effective 2024-08-01 in openFDA. Other nebivolol labels in openFDA, from generic sponsors, were not read. This page records label indications and the class only: no trial result and no dose is given.",
  "editorial_state": "draft",
  "last_substantive_edit": "2026-11-08",
  "last_evidence_check": "2026-11-08",
  "next_review_due": null,
  "identifiers": [
    {
      "scheme": "rxnorm",
      "value": "31555",
      "normalized_value": "31555",
      "match": "exact",
      "version": null,
      "label": null,
      "from_source": false
    },
    {
      "scheme": "unii",
      "value": "JGS34J7L9I",
      "normalized_value": "JGS34J7L9I",
      "match": "broad",
      "version": null,
      "label": null,
      "from_source": false
    },
    {
      "scheme": "mesh",
      "value": "D000068577",
      "normalized_value": "D000068577",
      "match": "exact",
      "version": "read 2026-11-08",
      "label": null,
      "from_source": false
    }
  ],
  "navigation": {
    "cardio": {
      "system": [
        "heart"
      ],
      "condition-area": [
        "hypertension"
      ]
    }
  },
  "payload": {
    "level": "substance",
    "mechanism": null
  },
  "content_digest": "df4cc2591bc44831f9e9406b778f2108f4b8fd17d652d888c7c10c41486e36cd",
  "review": {
    "content_digest": "df4cc2591bc44831f9e9406b778f2108f4b8fd17d652d888c7c10c41486e36cd",
    "current": [],
    "conflicting": [],
    "stale": [],
    "inactive": []
  },
  "claims": [
    {
      "release_id": "a25293eeae6350fb",
      "id": "cardio:claim-fda-nebivolol-label-indications",
      "owner": "cardio",
      "subject_entity_id": "cardio:nebivolol",
      "category": "descriptive",
      "statement": "The US label of BYSTOLIC (nebivolol hydrochloride), in the Allergan, Inc. version dated 2024-08-01 in openFDA, lists the medicine for the treatment of hypertension, to lower blood pressure.",
      "context": {
        "id": "cardio:ctx-fda-nebivolol-label-us",
        "label": "People for whom the US label of nebivolol (Bystolic) lists an indication: hypertension",
        "recipient": "unknown",
        "population": "Patients described in the indications section of the label. The label does not state an age range in the passage read.",
        "care_setting": "Prescription medicine, as described in the US label",
        "geography": "United States (label of the US Food and Drug Administration)",
        "life_stage_note": "Not stated in the label passage read",
        "life_stage_terms": null,
        "gestational_age_min_days": null,
        "gestational_age_max_days": null,
        "gestational_age_basis": null,
        "postnatal_age_min_days": null,
        "postnatal_age_max_days": null,
        "gestational_age_status": null,
        "postnatal_age_status": null,
        "followup_description": "Not applicable (label statement)",
        "eligibility": {
          "inclusion": [
            "Patients with hypertension"
          ],
          "exclusion": []
        }
      },
      "evidence_stage": "not_applicable",
      "certainty": "not_assessed",
      "certainty_method": null,
      "limitations": "This claim records what the label says the medicine is indicated for. It is not a finding about how well the medicine works, and no trial result is recorded for it in this atlas. The label may list other indications that were not recorded. Contraindications, doses, interactions and warnings were not read. Labels change, and openFDA also lists other versions with different dates. openFDA's own disclaimer says not to rely on it for decisions about medical care.",
      "editorial_state": "draft",
      "checked_at": "2026-11-08",
      "next_review_due": null,
      "valid_from": null,
      "valid_to": null,
      "citations": [
        {
          "evidence_role": "supports",
          "locator": "results[0].indications_and_usage[0], 1. INDICATIONS AND USAGE",
          "applicability_note": "The label sentences that give the indications named in the statement, each quoted in the research quote table.",
          "snapshot": {
            "id": "cardio:openfda-label-bystolic-2026-11-08",
            "retrieved_at": "2026-11-08T20:37:15Z",
            "content_hash": "272454333965f93512f2cc1866c29f068170de6a24c0b87238d21dba3f07fdef",
            "source_effective_date": "2024-08-01",
            "public_archive_url": null,
            "source_state": "current"
          },
          "source": {
            "id": "cardio:openfda-label-bystolic",
            "source_type": "regulator",
            "title": "openFDA drug label record for BYSTOLIC (nebivolol hydrochloride), Allergan, Inc. label: indications and substance identifiers",
            "canonical_url": "https://api.fda.gov/drug/label.json?search=set_id:%228b8ad213-1dc8-454e-a524-075685c0e1a8%22&limit=1",
            "identifiers": [],
            "publication_date": null,
            "publisher": "U.S. Food and Drug Administration (openFDA)",
            "edition": "The openFDA drug label record for set id 8b8ad213-1dc8-454e-a524-075685c0e1a8 (manufacturer Allergan, Inc., application NDA021742), returned on 2026-11-08. The label text is dated 2024-08-01 (effective_time). Other openFDA records of nebivolol labels from other sponsors and repackagers exist and were not used.",
            "reuse_basis": "openFDA data is public domain under a Creative Commons CC0 1.0 Universal dedication, as the openFDA licence page states (fetched 2026-11-08, sha256 7fda0041a24f8d7139a1781d4462ae39643a2ee6f3b0f079946c989a8e1982d2, hash only). Only short passages are quoted. The raw record is committed at research/snapshots/wa21-openfda-label-nebivolol.json.",
            "public_text": "quote",
            "replaced_by": null,
            "retirement_note": null
          }
        },
        {
          "evidence_role": "context",
          "locator": "results[0].effective_time",
          "applicability_note": "Effective date of the label text read, 20240801.",
          "snapshot": {
            "id": "cardio:openfda-label-bystolic-2026-11-08",
            "retrieved_at": "2026-11-08T20:37:15Z",
            "content_hash": "272454333965f93512f2cc1866c29f068170de6a24c0b87238d21dba3f07fdef",
            "source_effective_date": "2024-08-01",
            "public_archive_url": null,
            "source_state": "current"
          },
          "source": {
            "id": "cardio:openfda-label-bystolic",
            "source_type": "regulator",
            "title": "openFDA drug label record for BYSTOLIC (nebivolol hydrochloride), Allergan, Inc. label: indications and substance identifiers",
            "canonical_url": "https://api.fda.gov/drug/label.json?search=set_id:%228b8ad213-1dc8-454e-a524-075685c0e1a8%22&limit=1",
            "identifiers": [],
            "publication_date": null,
            "publisher": "U.S. Food and Drug Administration (openFDA)",
            "edition": "The openFDA drug label record for set id 8b8ad213-1dc8-454e-a524-075685c0e1a8 (manufacturer Allergan, Inc., application NDA021742), returned on 2026-11-08. The label text is dated 2024-08-01 (effective_time). Other openFDA records of nebivolol labels from other sponsors and repackagers exist and were not used.",
            "reuse_basis": "openFDA data is public domain under a Creative Commons CC0 1.0 Universal dedication, as the openFDA licence page states (fetched 2026-11-08, sha256 7fda0041a24f8d7139a1781d4462ae39643a2ee6f3b0f079946c989a8e1982d2, hash only). Only short passages are quoted. The raw record is committed at research/snapshots/wa21-openfda-label-nebivolol.json.",
            "public_text": "quote",
            "replaced_by": null,
            "retirement_note": null
          }
        }
      ],
      "review": {
        "content_digest": "f5c078ac4b6a7c2282e9c09b7cd3f1be5311dc2fb026977cb13c2ccbda801eea",
        "current": [],
        "conflicting": [],
        "stale": [],
        "inactive": []
      },
      "api_path": "api/v1/claims/cardio--claim-fda-nebivolol-label-indications.json"
    }
  ],
  "decisions": [],
  "milestones": [],
  "relationships": {
    "outgoing": [
      {
        "predicate": "subtype_of",
        "label": "Nebivolol is a beta-adrenergic blocker (FDA established pharmacologic class in RxClass)",
        "clinical_claim_not_fact": false,
        "family": "sourced",
        "other_entity_id": "cardio:beta-blockers",
        "other_entity_in_atlas": true,
        "claim_id": null,
        "evidence": {
          "snapshot_id": "cardio:rxclass-31555-2026-11-08",
          "locator": "rxclassDrugInfoList.rxclassDrugInfo[1].rxclassMinConceptItem.className"
        },
        "primary": true,
        "role": null,
        "valid_from": null,
        "valid_to": null
      },
      {
        "predicate": "evaluated_for",
        "label": "FDA label lists hypertension as an indication",
        "clinical_claim_not_fact": true,
        "family": "clinical",
        "other_entity_id": "core:hypertension",
        "other_entity_in_atlas": true,
        "claim_id": "cardio:claim-fda-nebivolol-label-indications",
        "evidence": null,
        "primary": false,
        "role": null,
        "valid_from": null,
        "valid_to": null
      },
      {
        "predicate": "part_of",
        "label": "Files under this front",
        "clinical_claim_not_fact": false,
        "family": "navigation",
        "other_entity_id": "cardio:front-medicines",
        "other_entity_in_atlas": true,
        "claim_id": null,
        "evidence": null,
        "primary": true,
        "role": null,
        "valid_from": null,
        "valid_to": null
      }
    ],
    "incoming": [
      {
        "predicate": "investigates",
        "label": "Investigated in",
        "clinical_claim_not_fact": false,
        "family": "sourced",
        "other_entity_id": "cardio:ct-nct01057251",
        "other_entity_in_atlas": true,
        "claim_id": null,
        "evidence": {
          "snapshot_id": "cardio:ctgov-nct01057251-2012-01-11",
          "locator": "protocolSection.armsInterventionsModule.interventions[0].name"
        },
        "primary": false,
        "role": null,
        "valid_from": null,
        "valid_to": null
      },
      {
        "predicate": "investigates",
        "label": "Investigated in",
        "clinical_claim_not_fact": false,
        "family": "sourced",
        "other_entity_id": "cardio:ct-nct01415531",
        "other_entity_in_atlas": true,
        "claim_id": null,
        "evidence": {
          "snapshot_id": "cardio:ctgov-nct01415531-2013-05-16",
          "locator": "protocolSection.armsInterventionsModule.interventions[0].name"
        },
        "primary": false,
        "role": null,
        "valid_from": null,
        "valid_to": null
      },
      {
        "predicate": "investigates",
        "label": "Investigated in",
        "clinical_claim_not_fact": false,
        "family": "sourced",
        "other_entity_id": "cardio:ct-nct03778554",
        "other_entity_in_atlas": true,
        "claim_id": null,
        "evidence": {
          "snapshot_id": "cardio:ctgov-nct03778554-2025-06-10",
          "locator": "protocolSection.armsInterventionsModule.interventions[3].name"
        },
        "primary": false,
        "role": null,
        "valid_from": null,
        "valid_to": null
      },
      {
        "predicate": "investigates",
        "label": "Investigated in",
        "clinical_claim_not_fact": false,
        "family": "sourced",
        "other_entity_id": "cardio:ct-nct05513937",
        "other_entity_in_atlas": true,
        "claim_id": null,
        "evidence": {
          "snapshot_id": "cardio:ctgov-nct05513937-2025-02-04",
          "locator": "protocolSection.armsInterventionsModule.interventions[0].name"
        },
        "primary": false,
        "role": null,
        "valid_from": null,
        "valid_to": null
      },
      {
        "predicate": "investigates",
        "label": "Investigated in",
        "clinical_claim_not_fact": false,
        "family": "sourced",
        "other_entity_id": "cardio:ct-nct06249802",
        "other_entity_in_atlas": true,
        "claim_id": null,
        "evidence": {
          "snapshot_id": "cardio:ctgov-nct06249802-2024-02-08",
          "locator": "protocolSection.armsInterventionsModule.interventions[0].name"
        },
        "primary": false,
        "role": null,
        "valid_from": null,
        "valid_to": null
      },
      {
        "predicate": "investigates",
        "label": "Investigated in",
        "clinical_claim_not_fact": false,
        "family": "sourced",
        "other_entity_id": "cardio:ct-nct06424834",
        "other_entity_in_atlas": true,
        "claim_id": null,
        "evidence": {
          "snapshot_id": "cardio:ctgov-nct06424834-2024-11-27",
          "locator": "protocolSection.armsInterventionsModule.interventions[1].name"
        },
        "primary": false,
        "role": null,
        "valid_from": null,
        "valid_to": null
      },
      {
        "predicate": "contains",
        "label": "Contained in",
        "clinical_claim_not_fact": false,
        "family": "sourced",
        "other_entity_id": "cardio:fdaprod-nda021742",
        "other_entity_in_atlas": true,
        "claim_id": null,
        "evidence": {
          "snapshot_id": "cardio:ofeed-nda021742-2023-06-16",
          "locator": "products[0].active_ingredients[0].name"
        },
        "primary": false,
        "role": "active",
        "valid_from": null,
        "valid_to": null
      },
      {
        "predicate": "contains",
        "label": "Contained in",
        "clinical_claim_not_fact": false,
        "family": "sourced",
        "other_entity_id": "cardio:fdaprod-nda206302",
        "other_entity_in_atlas": true,
        "claim_id": null,
        "evidence": {
          "snapshot_id": "cardio:ofeed-nda206302-2023-06-16",
          "locator": "products[0].active_ingredients[0].name"
        },
        "primary": false,
        "role": "active",
        "valid_from": null,
        "valid_to": null
      }
    ]
  },
  "page_path": "drugs/nebivolol/",
  "context_path": "api/v1/context/cardio--nebivolol.md"
}
